These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 16863782

  • 1. Differential effects of protein kinase C isoform activation in endothelin-mediated myocyte contractile dysfunction with cardioplegic arrest and reperfusion.
    Apple KA, McLean JE, Squires CE, Schaeffer B, Sample JA, Murphy RL, Deschamps AM, Leonardi AH, Allen CM, Hendrick JW, Stroud RE, Mukherjee R, Spinale FG.
    Ann Thorac Surg; 2006 Aug; 82(2):664-71. PubMed ID: 16863782
    [Abstract] [Full Text] [Related]

  • 2. Protein kinase C isoform activation and endothelin-1 mediated defects in myocyte contractility after cardioplegic arrest and reperfusion.
    Mukherjee R, Apple KA, Squires CE, Kaplan BS, McLean JE, Saunders SM, Stroud RE, Spinale FG.
    Circulation; 2006 Jul 04; 114(1 Suppl):I308-13. PubMed ID: 16820591
    [Abstract] [Full Text] [Related]

  • 3. Beneficial effects of myocyte preconditioning on contractile processes after cardioplegic arrest.
    Zellner JL, Hebbar L, Crawford FA, Mukherjee R, Spinale FG.
    Ann Thorac Surg; 1996 Feb 04; 61(2):558-64. PubMed ID: 8572767
    [Abstract] [Full Text] [Related]

  • 4. Contributory mechanisms for the beneficial effects of myocyte preconditioning during cardioplegic arrest.
    O SJ, Zellner JL, Cox MH, Hebbar L, Brothers TE, Mukherjee R, Tempel GE, Dorman BH, Crawford FA, Spinale FG.
    Circulation; 1996 Nov 01; 94(9 Suppl):II389-97. PubMed ID: 8901780
    [Abstract] [Full Text] [Related]

  • 5. Potassium channel opener-augmented cardioplegia: protection of myocyte contractility with chronic left ventricular dysfunction.
    Dorman BH, Hebbar L, Clair MJ, Hinton RB, Roy RC, Spinale FG.
    Circulation; 1997 Nov 04; 96(9 Suppl):II-253-9. PubMed ID: 9386107
    [Abstract] [Full Text] [Related]

  • 6. ATP-sensitive potassium channel activation before cardioplegia. Effects on ventricular and myocyte function.
    Dorman BH, Hebbar L, Zellner JL, New RB, Houck WV, Acsell J, Nettles C, Hendrick JW, Sampson AP, Mukherjee R, Spinale FG.
    Circulation; 1998 Nov 10; 98(19 Suppl):II176-83. PubMed ID: 9852901
    [Abstract] [Full Text] [Related]

  • 7. Cardiopulmonary bypass with cardioplegic arrest activates protein kinase C in the human myocardium.
    Sodha NR, Clements RT, Bianchi C, Sellke FW.
    J Am Coll Surg; 2008 Jan 10; 206(1):33-41. PubMed ID: 18155566
    [Abstract] [Full Text] [Related]

  • 8. Myocyte contractility with caspase inhibition and simulated hyperkalemic cardioplegic arrest.
    Mukherjee R, Yarbrough WM, Reese ES, Leiser JS, Sample JA, Mingoia JT, Hardin AE, Stroud RE, McLean JE, Hendrick JW, Spinale FG.
    Ann Thorac Surg; 2004 May 10; 77(5):1684-9; discussion 1689-90. PubMed ID: 15111166
    [Abstract] [Full Text] [Related]

  • 9. Direct and interactive effects of cardioplegic arrest and protamine on myocyte contractility.
    O SJ, Cox MH, Mukherjee R, Clair MJ, Crawford FA, Spinale FG.
    Ann Thorac Surg; 1996 Aug 10; 62(2):489-94. PubMed ID: 8694611
    [Abstract] [Full Text] [Related]

  • 10. Myocyte endothelin exposure during cardioplegic arrest exacerbates contractile dysfunction after reperfusion.
    Dorman BH, New RB, Bond BR, Mukherjee R, Mukhin YV, McElmurray JH, Spinale FG.
    Anesth Analg; 2000 May 10; 90(5):1080-5. PubMed ID: 10781456
    [Abstract] [Full Text] [Related]

  • 11. Endothelin-1 and PKC induce positive inotropy without affecting pHi in ventricular myocytes.
    Kang M, Walker JW.
    Exp Biol Med (Maywood); 2006 Jun 10; 231(6):865-70. PubMed ID: 16741014
    [Abstract] [Full Text] [Related]

  • 12. Protein kinase C activation before cardioplegic arrest: beneficial effects on myocyte contractility.
    O SJ, Cox MH, Crawford FA, Spinale FG.
    J Thorac Cardiovasc Surg; 1997 Oct 10; 114(4):651-9. PubMed ID: 9338652
    [Abstract] [Full Text] [Related]

  • 13. Protein kinase C delta and epsilon mediate positive inotropy in adult ventricular myocytes.
    Kang M, Walker JW.
    J Mol Cell Cardiol; 2005 May 10; 38(5):753-64. PubMed ID: 15850569
    [Abstract] [Full Text] [Related]

  • 14. Endothelin-1-induced phospholipase C-beta and D and protein kinase C isoenzyme signaling leading to hypertrophy in rat cardiomyocytes.
    Lamers JM, Eskildsen-Helmond YE, Resink AM, de Jonge HW, Bezstarosti K, Sharma HS, van Heugten HA.
    J Cardiovasc Pharmacol; 1995 May 10; 26 Suppl 3():S100-3. PubMed ID: 8587331
    [Abstract] [Full Text] [Related]

  • 15. Overexpression of diacylglycerol kinase zeta inhibits endothelin-1-induced decreases in Ca2+ transients and cell shortening in mouse ventricular myocytes.
    Nishimaru K, Arimoto T, Takeishi Y, Kubota I, Ishii K, Endoh M.
    J Mol Cell Cardiol; 2008 Mar 10; 44(3):520-6. PubMed ID: 18275971
    [Abstract] [Full Text] [Related]

  • 16. A dual-component positive inotropic effect of endothelin-1 in guinea pig left atria: a role of protein kinase C.
    Hattori Y, Nakaya H, Nishihira J, Kanno M.
    J Pharmacol Exp Ther; 1993 Sep 10; 266(3):1202-12. PubMed ID: 7690398
    [Abstract] [Full Text] [Related]

  • 17. Differential activation of protein kinase C isoforms following chemical ischemia in rat cerebral cortex slices.
    Selvatici R, Falzarano S, Franceschetti L, Cavallini S, Marino S, Siniscalchi A.
    Neurochem Int; 2006 Dec 10; 49(8):729-36. PubMed ID: 16963162
    [Abstract] [Full Text] [Related]

  • 18. Influence of endothelin receptor antagonists on myocardial protein kinase C isoforms in uraemic cardiomyopathy.
    Wolf SC, Amend T, Risler T, Amann K, Brehm BR.
    Clin Sci (Lond); 2002 Aug 10; 103 Suppl 48():276S-279S. PubMed ID: 12193103
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of protein kinase C alpha improves myocardial beta-adrenergic receptor signaling and ventricular function in a model of myocardial preservation.
    D'Souza KM, Petrashevskaya NN, Merrill WH, Akhter SA.
    J Thorac Cardiovasc Surg; 2008 Jan 10; 135(1):172-9, 179.e1. PubMed ID: 18179937
    [Abstract] [Full Text] [Related]

  • 20. Cellular and molecular therapeutic targets for treatment of contractile dysfunction after cardioplegic arrest.
    Spinale FG.
    Ann Thorac Surg; 1999 Nov 10; 68(5):1934-41. PubMed ID: 10585107
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.